MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer

Prostate cancer (PCa) is one of the most commonly diagnosed cancers among men worldwide. Despite the presence of accumulated clinical strategies for PCa management, limited prognostic/sensitive biomarkers are available to follow up on disease occurrence and progression. MicroRNAs (miRNAs) are small...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghamlouche, Fatima, Yehya, Amani, Zeid, Yousef, Fakhereddine, Hiam, Fawaz, Jhonny, Liu, Yen-Nien, Al-Sayegh, Mohamed, Abou-Kheir, Wassim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827391/
https://www.ncbi.nlm.nih.gov/pubmed/36608541
http://dx.doi.org/10.1016/j.tranon.2022.101613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827391/
https://www.ncbi.nlm.nih.gov/pubmed/36608541
http://dx.doi.org/10.1016/j.tranon.2022.101613

Ejemplares similares